Skip to main content

Drugs administered other than oral method, chemotherapy drugs (J codes): codes J9275 to J9601 (page 6 of 6)

This page continues the code list of the Drugs administered other than oral method, chemotherapy drugs (J codes) hub, which holds 847 active HCPCS Level II codes from the October 2026 CMS file, 809 of them with a full reference page. It shows the 71 codes from J9275 to J9601. Each row carries the October 2026 Medicare Part B payment limit per billing unit (or the OPPS rate for drugs paid separately under the outpatient system), the practitioner MUE, the number of NCCI column-2 pairs and whether a Medicare coverage article lists the code.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Codes J9275 to J9601

Page 6 of 6 of the hub's 847 codes, in code order: 70 codes on this page have an indexed reference page and are in the table, and the other 1 are listed as text below it.

Drugs administered other than oral method, chemotherapy drugs (J codes): codes J9275 to J9601 with an indexed reference page
CodeDescriptorUnitLimitMUECol-2 pairsArticles
J9275Injection, cosibelimab-ipdl, 2 mg2 MG$21.989600——
J9276Injection, zanidatamab-hrii, 2 mg2 MG$25.7341500——
J9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph1 MG$32.307———
J9278Injection, carboplatin (avyxa), 1 mg1 MG$5.226———
J9280Injection, mitomycin, 5 mg5 MG$34.83812——
J9281Mitomycin pyelocalyceal instillation, 1 mg1 MG$329.07180——
J9282Mitomycin, intravesical instillation, 1 mg1 MG$272.91880——
J9286Injection, glofitamab-gxbm, 2.5 mg2.5 MG$2,859.11712——
J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhy2 MG$27.989600——
J9292Injection, pemetrexed dipotassium, 10 mg10 MG$76.69150——
J9293Injection, mitoxantrone hydrochloride, per 5 mg5 MG$19.4188——
J9294Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg10 MG$3.678150——
J9295Injection, necitumumab, 1 mg1 mg$5.731 OPPS800——
J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg10 MG$4.879150——
J9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg3 mg/1 mg$205.442160——
J9299Injection, nivolumab, 1 mg1 MG$34.191480——
J9301Injection, obinutuzumab, 10 mg10 MG$85.039100——
J9303Injection, panitumumab, 10 mg10 MG$183.27590——
J9304Injection, pemetrexed (pemfexy), 10 mg10 MG$92.505150——
J9305Injection, pemetrexed, not otherwise specified, 10 mg10 MG$1.23150——
J9306Injection, pertuzumab, 1 mg1 MG$17.269840——
J9307Injection, pralatrexate, 1 mg1 MG$384.57280——
J9308Injection, ramucirumab, 5 mg5 MG$76.398280——
J9309Injection, polatuzumab vedotin-piiq, 1 mg1 MG$144.103280——
J9311Injection, rituximab 10 mg and hyaluronidase10 mg$36.265160—yes
J9312Injection, rituximab, 10 mg10 MG$72.094150—yes
J9314Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg10 MG$10.986150——
J9316Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg10 MG$59.491180——
J9317Injection, sacituzumab govitecan-hziy, 2.5 mg2.5 MG$37.536648——
J9318Injection, romidepsin, non-lyophilized, 0.1 mg0.1 MG$32.864475——
J9319Injection, romidepsin, lyophilized, 0.1 mg0.1 MG$32.343500——
J9321Injection, epcoritamab-bysp, 0.16 mg0.16 MG$57.975300——
J9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg10 mg$10.60 OPPS150——
J9324Injection, pemetrexed (pemrydi rtu), 10 mg10 MG$63.58150——
J9325Injection, talimogene laherparepvec, per 1 million plaque forming units1 millionPFU$77.657400——
J9326Injection, telisotuzumab vedotin-tllv, 1 mg1 MG$145.946200——
J9328Injection, temozolomide, 1 mg1 MG$10.41400——
J9329Injection, tislelizumab-jsgr, 1mg1 MG$58.086400——
J9330Injection, temsirolimus, 1 mg1 MG$27.70750——
J9331Injection, sirolimus protein-bound particles, 1 mg1 MG$91.03300——
J9332Injection, efgartigimod alfa-fcab, 2mg2 MG$32.347600——
J9333Injection, rozanolixizumab-noli, 1 mg1 MG$23.626840——
J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc2 MG$33.59504——
J9341Injection, thiotepa (tepylute), 1 mg1 MG$37.84160——
J9342Injection, thiotepa, not otherwise specified, 1 mg1 MG$5.87160——
J9345Injection, retifanlimab-dlwr, 1 mg1 MG$30.932500——
J9347Injection, tremelimumab-actl, 1 mg1 MG$146.991300——
J9348Injection, naxitamab-gqgk, 1 mg1 MG$685.988160——
J9349Injection, tafasitamab-cxix, 2 mg2 MG$14.428900——
J9350Injection, mosunetuzumab-axgb, 1 mg1 MG$676.48460——
J9351Injection, topotecan, 0.1 mg0.1 MG$2.067120——
J9353Injection, margetuximab-cmkb, 5 mg5 MG$56.046450——
J9354Injection, ado-trastuzumab emtansine, 1 mg1 MG$43.86600——
J9355Injection, trastuzumab, excludes biosimilar, 10 mg10 MG$68.871120——
J9356Injection, trastuzumab, 10 mg and hyaluronidase-oysk10 MG$58.03860——
J9357Injection, valrubicin, intravesical, 200 mg200 MG$1,230.6644——
J9358Injection, fam-trastuzumab deruxtecan-nxki, 1 mg1 MG$32.6531000——
J9359Injection, loncastuximab tesirine-lpyl, 0.075 mg0.075 MG$226.565400——
J9360Injection, vinblastine sulfate, 1 mg1 MG$5.75440——
J9361Injection, efbemalenograstim alfa-vuxw, 0.5 mg0.5 MG$121.42940——
J9362Injection, trabectedin, 0.01 mg0.01 MG$41.844———
J9370Vincristine sulfate, 1 mg1 MG$9.4264——
J9380Injection, teclistamab-cqyv, 0.5 mg0.5 MG$35.818918——
J9381Injection, teplizumab-mzwv, 5 mcg5 MCG$39.274800——
J9382Injection, zenocutuzumab-zbco, 1 mg1 MG$33.869750——
J9390Injection, vinorelbine tartrate, 10 mg10 MG$4.14836——
J9393Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg25 mg$41.67 OPPS20——
J9395Injection, fulvestrant, 25 mg25 MG$5.02120——
J9400Injection, ziv-aflibercept, 1 mg1 MG$9.702500——
J9601Injection, linvoseltamab-gcpt, 1 mg1 MG$99.134———
Show the other 1 codes on this page (pages not yet in search results)
  • J9376 Injection, pozelimab-bbfg, 1 mg · OPPS $91.73

How to read this page

The limit is the Medicare Part B payment allowance per billing unit for the October 2026 quarter, not per dose: divide the quantity administered by the unit in the descriptor to get the units billed, then multiply. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead, and codes without a limit are priced by the contractor or carry a limit of zero in the CMS file. The MUE column is the practitioner Medically Unlikely Edit, the most units CMS expects on one date of service; the facility and supplier limits can differ and are on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that a Medicare Administrative Contractor lists in a current billing and coding article.

Codes are listed in code order across 6 pages, and every code of the hub appears on exactly one of them. A code shown as text still has its own reference page with the same data; that page is kept out of search results because fewer CMS files join to the code, few people search for it, or its text is too close to another code's page, and the hub links the pages that are meant to be found. Amounts are Medicare national figures before locality and state adjustment.

Finding a code faster

Look up any code by number with the code search, or go back to the Drugs administered other than oral method, chemotherapy drugs (J codes) hub for its most searched codes and the answers to common questions. The MUE lookup shows every unit limit for a code, the NCCI edit checker tests whether two codes are bundled, and the HCPCS code lookup lists every range, drug and drug-class hub. For a drug you know by name, the J code index by drug name lists every code a generic or brand name bills under, and the ASP pricing file guide explains how the quarterly limits are set.

For teams evaluating QuickIntell software

Evaluate software for HCPCS coding workflows

Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Operational reference compiled from CMS publications. Amounts are Medicare national figures before locality and state adjustment; other payers differ. CPT codes appear as numbers only. This continuation page is kept out of search results; the hub and each code's own page are the pages meant to be found. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.